Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Environ Toxicol Chem ; 38(6): 1198-1210, 2019 06.
Artigo em Inglês | MEDLINE | ID: mdl-30901092

RESUMO

The trophic magnification of polybrominated diphenyl ethers (PBDEs) and selected nonlegacy halogenated organic compounds (HOCs) was determined in the food web of Lake Ontario (ON, Canada). In all, 28 Br3 -Br8 -PBDEs and 24 HOCs (10 of which had not been targeted previously) were analyzed. Average concentrations of Σ28 PBDEs in fish ranged between 79.7 ± 54.2 ng/g lipid weight in alewife (Alosa pseudoharengus) and 815 ± 695 ng/g lipid weight in lake trout (Salvelinus namaycush). For invertebrates, concentrations were between 13.4 ng/g lipid weight (net plankton; >110 µm) and 41.9 ng/g lipid weight in Diaporeia (Diaporeia hoyi). Detection frequency (DF) for HOCs was highest for anti-Dechlorane Plus (anti-DDC-CO), 1,3-diiodobenzene (1,3-DiiB), tribromo-methoxy-methylbenzene (ME-TBP), allyl 2,4,6-tribromophenyl ether (TBP-AE), pentabromocyclododecene (PBCYD), α+ß-tetrabromocylcooctane (TBCO), 2-bromoallyl 2,4,6-tribromophenyl ether (BATE), and pentabromotoluene (PBT; DF for all = 100% in lake trout). Tetrabromoxylene (TBX), dibromopropyl 2,4,6-tribromophenyl ether (TBP-DBPE), and syn-DDC-CO were also frequently detected in trout (DF = 70-78%), whereas 2,3,4,5,6-pentabromoethyl benzene (PBEB) was detected only in plankton. Several HOCs were reported in aquatic biota in the Great Lakes (USA/Canada) for the first time in the present study, including PBCYD, 1,3DiiB, BATE, TBP-DBPE, PBT, α + ß-TBCO, and ME-TBP. The Br4-6 -BDEs (-47, -85, -99, -100, -153, and -154) all had prey-weighted biomagnification factors (BMFPW ) values >6, whereas BMFPW values for Br7-8 -BDEs were <1. The highest BMFPW values of non-PBDEs were for TBP-DBPE (10.6 ± 1.34) and ME-TBP (4.88 ± 0.60), whereas TBP-AE had a BMFPW value of <1. Significant (p ≤ 0.05) trophic magnification factors (TMFs), both positive and negative, were found for Br4-8- BDEs (BDE 196 = 0.4; BDE 154 = 9.5) and for bis(2,4,6-tribromophenoxy)ethane (BTBPE; 0.53), PBCYD (1.8), 1,3-DiiB (0.33), and pentabromobenzene (PBB; 0.25). Food chain length was found to have a significant influence on the TMF values. Environ Toxicol Chem 2019;38:1198-1210. © 2019 SETAC.


Assuntos
Monitoramento Ambiental , Retardadores de Chama/análise , Hidrocarbonetos Halogenados/análise , Lagos/química , Animais , Bioacumulação , Ecossistema , Cadeia Alimentar , Geografia , Ontário , Plâncton/metabolismo , Truta/metabolismo , Poluentes Químicos da Água/análise
2.
J Pediatr Urol ; 8(1): 97-102, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21115401

RESUMO

OBJECTIVE: We present the initial clinical results of the 'modified Barry technique' for the prevention of VUR in paediatric renal transplant grafts. Ours is the only centre in the UK using this technique, as confirmed in a questionnaire developed in our department. PATIENTS AND METHODS: We retrospectively analysed data of 15 paediatric renal transplant patients (operated June 2006-November 2009) who had their vesicoureteric anastomosis performed using the modified Barry technique with a 2-cm submucosal anti-reflux tunnel. The original Barry technique involved the creation of a 4-cm tunnel; this was modified by us to reduce the risk of ureteric stenosis. RESULTS: At a median follow up of 23.7 months (6.3-39.4), the incidence of VUR was 7% (1/15). There was no evidence of postoperative urological complications, such as urinary leak, primary ureteric obstruction including anastomotic stricture/stenosis, transplant graft renal calculi and chronic rejection. At current follow up, graft and patient survival are 100%. CONCLUSION: With the introduction of the modified Barry technique, the incidence of VUR in our series fell 10-fold to 7%, compared with our earlier study (P<0.0001), without any urological complications. Although the initial results are encouraging, larger patient numbers and longer follow up are required to validate this technique further.


Assuntos
Cistostomia/métodos , Transplante de Rim/efeitos adversos , Prevenção Primária/métodos , Obstrução Ureteral/prevenção & controle , Refluxo Vesicoureteral/prevenção & controle , Adolescente , Cadáver , Criança , Pré-Escolar , Estudos de Coortes , Feminino , Seguimentos , Rejeição de Enxerto , Sobrevivência de Enxerto , Humanos , Falência Renal Crônica/cirurgia , Transplante de Rim/métodos , Doadores Vivos , Masculino , Estudos Retrospectivos , Medição de Risco , Resultado do Tratamento , Obstrução Ureteral/etiologia , Refluxo Vesicoureteral/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA